HIV prevention jab approved for use in England and Wales – here’s how it works

Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.

New menopause drug to target hot flashes without hormones gets FDA approval

The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday.

FDA approves nonhormonal drug to ease menopause hot flashes and night sweats

The federal Food and Drug Administration today approved a new menopause drug that reduces hot flashes and night sweats after ...

Inhibrx: Positive Ozekibart Data For Bone Cancer Leads To Q2 2026 BLA Filing

Inhibrx Biosciences, Inc. reports strong phase 2 results for ozekibart in chondrosarcoma, with new cancer data and key ...
The Motley Fool

AI Adoption Statistics: How Many Businesses Are Using AI?

National AI usage among businesses is 9.2%, with a projected increase to 11.6% in six months. Utah leads state AI business adoption at 15.7%%; Delaware's projected rate is highest at 19.1%.
MedPage Today on MSN

Novel Nonhormonal Drug Approved for Menopause Hot Flashes

The FDA approved elinzanetant (Lynkuet), a new type of nonhormonal drug to treat disruptive menopausal hot flashes, Bayer ...